RESEARCH DEVELOPMENT PROPHYLACTIC

Brand Owner Address Description
TERRAPIN TERRAPIN TECHNOLOGIES, INC. 165 EIGHTH STREET, SUITE 306 SAN FRANCISCO CA 94103 research and development of prophylactic and therapeutic pharmaceuticals for others; chemical analysis, identification, detection and measurement evaluations of compounds for new pharmaceuticals;
 

Where the owner name is not linked, that owner no longer owns the brand

    
Technical Examples
  1. A bacterial ?1,3-fucosyltransferase gene and deduced amino acid sequence is provided. The gene is useful for preparing ?1,3-fucosyltransferase polypeptide, and active fragment thereof, which can be used in the production of oligosaccharides such as Lewis X, Lewis Y, and siayl Lewis X, which are structurally similar to certain tumor-associated carbohy-drate antigens found in mammals. These product glycoconjugates also have research and diagnostic utility in the development of assays to detect mammalian tumors. In addition the polypeptide of the invention can be used to develop diagnostic and research assays to determine the presence of H. pylori in human specimens.